Prospera Financial Services’s Puma Biotechnology PBYI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $656K | Buy |
191,244
+6,987
| +4% | +$24K | 0.01% | 813 |
|
|
2025
Q1 | $545K | Buy |
184,257
+6,362
| +4% | +$18.8K | 0.01% | 751 |
|
|
2024
Q4 | $543K | Buy |
177,895
+9,010
| +5% | +$27.5K | 0.01% | 720 |
|
|
2024
Q3 | $431K | Buy |
168,885
+19,315
| +13% | +$49.3K | 0.01% | 776 |
|
|
2024
Q2 | $488K | Buy |
149,570
+1,778
| +1% | +$5.8K | 0.01% | 721 |
|
|
2024
Q1 | $783K | Buy |
147,792
+4,575
| +3% | +$24.2K | 0.02% | 561 |
|
|
2023
Q4 | $620K | Buy |
143,217
+20,325
| +17% | +$88K | 0.02% | 590 |
|
|
2023
Q3 | $323K | Buy |
122,892
+14,444
| +13% | +$38K | 0.01% | 773 |
|
|
2023
Q2 | $383K | Buy |
108,448
+8,376
| +8% | +$29.6K | 0.01% | 697 |
|
|
2023
Q1 | $309K | Buy |
100,072
+11,750
| +13% | +$36.3K | 0.01% | 772 |
|
|
2022
Q4 | $374K | Buy |
88,322
+6,075
| +7% | +$25.7K | 0.02% | 626 |
|
|
2022
Q3 | $195K | Buy |
82,247
+8,823
| +12% | +$20.9K | 0.01% | 783 |
|
|
2022
Q2 | $209K | Buy |
73,424
+13,744
| +23% | +$39.1K | 0.01% | 724 |
|
|
2022
Q1 | $172K | Buy |
59,680
+23,648
| +66% | +$68.2K | 0.01% | 928 |
|
|
2021
Q4 | $110K | Buy |
36,032
+672
| +2% | +$2.05K | ﹤0.01% | 847 |
|
|
2021
Q3 | $248K | Buy |
35,360
+9,615
| +37% | +$67.4K | 0.01% | 712 |
|
|
2021
Q2 | $236K | Buy |
25,745
+3,977
| +18% | +$36.5K | 0.01% | 722 |
|
|
2021
Q1 | $212K | Buy |
21,768
+2,940
| +16% | +$28.6K | 0.01% | 708 |
|
|
2020
Q4 | $193K | Buy |
+18,828
| New | +$193K | 0.01% | 647 |
|
|
2020
Q3 | – | Sell |
-12,186
| Closed | -$127K | – | 1675 |
|
|
2020
Q2 | $127K | Buy |
+12,186
| New | +$127K | 0.01% | 558 |
|